Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ubiquitome's Liberty16 Pro ready to carve up next COVID wave 2022-07-28 20:39
The Clinician and Clalit Health Services partner to drive value-based care and digital care pathway implementation in Israel 2022-07-28 12:33
Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis 2022-07-27 21:30
Noul's Hydrogel Stamping is the potential core technology necessary for precise cancer diagnosis, study confirmed 2022-07-27 20:00
Samsung Biologics Reports Second Quarter 2022 Financial Results 2022-07-27 14:43
Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus 2022-07-26 22:09
Gracell Biotechnologies to Participate in BTIG 2022 Biotechnology Conference 2022-07-26 20:30
Motex Showcases Award-Winning Face Masks in Miami at FIME 2022 2022-07-26 20:00
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Provisional Registration in Australia for Use in Adolescents Aged 12 Through 17 2022-07-26 20:00
Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study participants in HKU Clinical Trials Centre 2022-07-26 17:04
Otsuka Pharmaceuticals Implements Antibody Discovery, and Cell & Gene Therapy Research & Development by Utilizing the Berkeley Lights Beacon® Platform 2022-07-26 11:43
Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program 2022-07-25 21:59
Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA 2022-07-25 18:47
Fuzhou Rides on the Opportunity of "Digital China" to Make Its Name in the World 2022-07-25 15:21
Qiming's Portfolio Company InventisBio Lists on STAR Market 2022-07-25 11:55
4DMedical Lauds U.S. House of Representatives for Including Burn Pit Population Surveillance in FY 2023 Appropriations 2022-07-23 00:59
Ascentage Pharma Announces Clinical Trial Application for Olverembatinib (HQP1351) Approved in Canada 2022-07-22 07:59
AI-based Cancer Solution Pioneer Lunit Makes Market Debut 2022-07-21 21:00
ImmVira's intravenous administered oHSV MVR-T3011 IV demonstrated promising clinical biological activities 2022-07-21 08:00
Recruitment complete for Clarity's PROPELLER prostate cancer diagnostic trial 2022-07-20 21:06
1 119 120 121 122 123 432